To further differentiate the role of STING activation in host versus cancer cells, the expression levels of STING-downstream genes (Ifnβ and Cxcl9) in immune cells (CD45+) and cancer cells (CD45-) of the TME were quantified. This evidence concerns the gene PTPRC and cancer.